Tripos Releases Newest Version of Benchware Discovery 360 – Its Powerful, Enterprise-Wide, Pharmaceutical Research Software
ST. LOUIS–(BUSINESS WIRE)–Tripos™, a leading provider of drug discovery informatics products and services, today announced the release and general availability of Benchware® Discovery 360 (D360) Version 5.0. This newest release expands on the robust data access and analysis capabilities of previous D360 versions, by adding full featured forms-based querying and browsing, a data access dashboard for fast simple access to data searches, and a wide range of user requested integration options.
According to Tripos’ Chief Operating Officer, Patrick Flanagan, “Benchware D360 is the only commercially available, enterprise-wide informatics system providing all the functionality normally sought in the development of custom, in-house data access and analysis projects. Systems developed in-house are costly to build and take years to develop and implement. Additionally, in-house systems require a significant long term financial and personal commitment to deliver the long term value and to justify the expense of its creation and operation. Benchware D360 has proven that it meets the performance and scalability requirements necessary to be deployed at the largest pharmaceutical organizations, and yet it is affordable and flexible enough to address the needs of life sciences research organizations of all sizes.”
Tripos’ Benchware Discovery 360 Product Manager, David R. Lowis, D.Phil., says, “In a research environment, Discovery 360 removes data access and analysis bottlenecks, and improves overall research efficiency. The latest version provides a full, rich and easy to use Forms capability, allowing researchers to easily browse very rich, hierarchical views of research data to get a fuller perspective on their candidate drugs. The user-customizable dashboard allows users to get to the data views they want in a matter of seconds and is modeled on Web tools that will be familiar to all. Emphasis on the new release of D360 has been on maintaining high standards of usability and flexibility while extending the fundamental data query, presentation and ease of access for all research roles from chemistry and biology to drug safety and metabolism.”
About Tripos
Tripos, a Certara™ Company, is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Established in 1979, Tripos was the first company to bring scientific computational drug discovery capabilities to the pharmaceutical, chemical and food design industries, and today helps a broad range of companies and research facilities accelerate the identification and optimization of new compounds that have the potential to become marketed drugs, foods, flavorings and fragrances. Headquartered in St. Louis, Missouri, Tripos serves more than 1,000 customers spanning over 46 countries.
About Certara
Certara is dedicated to improving human health through a broad spectrum of products and services, from molecular discovery to clinical research. Formed in 2008, Certara unites Tripos (www.tripos.com) and Pharsight Corporation (www.pharsight.com). Tripos provides innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Pharsight provides software and scientific services to improve productivity and decision-making in clinical drug development. Certara focuses on reducing the barriers between the phases of research to speed discoveries in chemistry, and enabling pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products.
